[Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010646:Phentolamine / Q000627:therapeutic use*; D011224:Prazosin / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; D014665:Vasodilator Agents; D011224:Prazosin; D010646:Phentolamine
Vasodilatatoren-Therapie mit Alpha-Rezeptorenblockern. Akute und chronische Wirkungen von Prazosin und Phentolamin bei kongestiver Herzinsuffizienz.